VRTX vs ABBV
Vertex Pharmaceuticals vs AbbVie — AI-powered side-by-side comparison
| Metric | VRTX | ABBV |
|---|---|---|
| AI Score | 55 | 54 |
| Price | $485.36 | $247.97 |
| P/E Ratio | 30.05× | 121.64× |
| ROE | 23.9% | -1.3% |
| Revenue Growth YoY | 10.1% | — |
| Gross Margin | 86.2% | 0.7% |
| Debt / Equity | 0.01× | 2.65× |
| Dividend Yield | — | 0.0% |
| RSI (14) | 43.8 | 53.2 |
| Beta | 0.2937 | 0.283 |
| Expected Upside | +0.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
VRTX Full Analysis
ABBV Full Analysis